Event Details
European Society of Cardiology (ESC) Congress 2026
Aug 28 - Aug 31, 2026
Title: Plozasiran in patients with severe hypertriglyceridemia: the SHASTA-3 and SHASTA-4 pivotal trial 12-month results
Session: HOT LINE 9 Late-breaking Science Session
Date/Time: August 30, 2026, 17:30 CEST
Presenter: Gerald Watts
Title: A phase 3 clinical trial to evaluate the efficacy and safety of vsa003 (zodasiran) injection in Chinese adolescents and adults with homozygous familial hypercholesterolemia (HOFH)
Session: Late-breaking science: Beyond statins: the next wave of lipid-lowering therapies
Date/Time: August 31, 2026, 9:00 am CEST
Presenter: Zhuang Tian, Peking Union Medical College Hospital, Beijing, China